Pharmaceutical company Quality Chemicals Limited is expected to produce a new medication in November to reduce the risk of mother-to-child HIV transmission in Uganda, The Monitor/allafrica.com reports. More than 25,000 children in the sub-Saharan African country become infected with the virus through breast feeding each year.

“These drugs will allow [HIV] positive mothers to safely breast-feed without any worry of infecting their children,” said George Baguma, the company's marketing director.

According to the article, only 12,000 of the country's 50,000 children eligible for antiretroviral therapy have access to it. Without treatment, many of Uganda's HIV-positive children die before the age of 5.

The country's National Drug Authority has licensed a plant near the city of Kampala to manufacture the triple therapy combination drug, which Baguma said will be a once-a-day tablet. Quality Chemicals Limited is still waiting for licenses from the World Health Organization (WHO) and the United States Food and Drug Authority (FDA).